De-identified Human Tissue Project
Research scientists of the University of Central Florida College of Medicine (COM) and Burnett School of Biomedical Sciences (BSBS) conduct laboratory studies in biomedical and translational medical research for the purpose of understanding human disease and developing innovative methods for diagnosing, measuring, or treating disease or disease symptoms. The key research divisions are cancer, cardiovascular, immunity and pathogenesis, neuroscience, and molecular microbiology.
Conditions:
🦠 Tissue
🗓️ Study Start (Actual) 14 September 2022
🗓️ Primary Completion (Estimated) September 2027
✅ Study Completion (Estimated) September 2027
👥 Enrollment (Estimated) 1000000
🔬 Study Type OBSERVATIONAL
📊 Phase N/A
Locations:
📍 Orlando, Florida, United States

📋 Eligibility Criteria

Description

  • Inclusion:
  • - de-identified human tissue from cooperating institutions for unknown/undisclosed donors.
Ages Eligible for Study: 18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: Yes

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 3 October 2023
  • First Submitted that Met QC Criteria 8 October 2023
  • First Posted 13 October 2023

Study Record Updates

  • Last Update Submitted that Met QC Criteria 17 October 2023
  • Last Update Posted 19 October 2023
  • Last Verified October 2023